FDA Opens Third Salmonella–Moringa Outbreak Investigation of the Year
The U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) have reopened a foodborne illness outbreak investigation involving Salmonella-contaminated moringa powder supplements. At the same time, the agency has opened a new investigation into a separate Salmonella–moringa outbreak, marking the third outbreak caused by this pathogen–commodity pair in 2026.
Outbreak Investigation Reopened With 22 New Illnesses
First, FDA and CDC reopened an outbreak investigation that was originally closed on March 17 due to the discovery of new information. Since March 17, 22 additional people from four states have been infected with one of the outbreak strains of S. Typhimurium or S. Newport, bringing the total to 119 patients in 36 states, including 32 hospitalizations.
The list of recalled products has been expanded to include TNvitamins-brand Ultra Potent Complete Green Superfood Moringa capsules and Doctor’s Pride Complete Green Superfood Ultra Potent Moringa capsules distributed by Total Nutrition Inc. to retailers across the U.S.
FDA Announces Third Salmonella-Moringa Outbreak of 2026
On May 27, FDA announced it is investigating another multistate outbreak of Salmonella Typhimurium infections linked to MOGO-brand moringa powder capsules distributed by MOGO Moringa LLC of St. Louis, Missouri.
Based on epidemiological information collected by CDC, a total of 18 people infected with the outbreak strain of Salmonella have been reported from 14 states. Illness onset ranges from February 3 to April 7, 2026. Of the eight people interviewed, six reported eating moringa powder capsules, including four who reported MOGO-brand moringa powder capsules. There have been seven hospitalizations, and no deaths have been reported.
MOGO Moringa LLC has recalled certain lots of MOGO-brand Pure Moringa Oleifera capsules. FDA is conducting a traceback investigation to determine the source of contamination and is working with state partners to collect samples.
Moringa Supply Chain Vulnerabilities
Aside from the two currently open foodborne illness outbreak investigations involving Salmonella-contaminated moringa, FDA closed a third outbreak investigation in April 2026 regarding moringa supplements contaminated with “extensively drug-resistant” Salmonella.
Three outbreaks in the same year involving moringa products shine a light on a broader issue that affects many botanical ingredients used in the global natural health industry. While moringa has gained widespread popularity for its nutritional profile and potential wellness benefits, recent contamination incidents highlight vulnerabilities that can arise when supply chains lack sufficient transparency, testing protocols, and oversight. Written for Food Safety Magazine in light of the uptick in moringa recalls, this expert-authored column examines where problems can emerge in botanical ingredient supply chains and how companies can better protect consumer safety.
Looking for quick answers on food safety topics?
Try Ask FSM, our new smart AI search tool.
Ask FSM →
